SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-17-026141
Filing Date
2017-07-25
Accepted
2017-07-25 17:17:26
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 112107
  Complete submission text file 0000000000-17-026141.txt   155142
Mailing Address 425 MADISON AVENUE, SUITE 902 NEW YORK NY 10017
Business Address 425 MADISON AVENUE, SUITE 902 NEW YORK NY 10017 212-874-6608
AngioGenex, Inc. (Filed for) CIK: 0001085596 (see all company filings)

IRS No.: 860945116 | State of Incorp.: NV | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations